Escalon Medical Corp
ESMC
ESMC was delisted on the 17th of November, 2016.
8 hedge funds and large institutions have $893K invested in Escalon Medical Corp in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
18% more capital invested
Capital invested by funds: $760K → $893K (+$133K)
20% less funds holding
Funds holding: 10 → 8 (-2)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$13K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$8.24K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$1.49K |
| 4 |
Renaissance Technologies
New York
|
-$406 |
ESMC Hedge Fund Activity: Q3 2013 in Review
8 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Escalon Medical Corp (ESMC) for Q3 2013, worth a combined $893K — up 18% from $760K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ESMC and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Vanguard Group, adding an estimated $53K. The largest seller was Citadel Advisors, exiting entirely with an estimated $13K sold.
- 8 institutional investors held Escalon Medical Corp (ESMC) as of Q3 2013, down from 10 in Q2 2013.
- Funds reported $893K of Escalon Medical Corp stock for Q3 2013, up 18% quarter-over-quarter.
- 0 funds opened new Escalon Medical Corp positions in Q3 2013 and 2 closed out, a net change of -2 holders.
- The largest Escalon Medical Corp buyer in Q3 2013 was Vanguard Group, an estimated $53K added.
- The largest Escalon Medical Corp seller in Q3 2013 was Citadel Advisors, an estimated $13K sold.
Based on aggregated 13F filings for Q3 2013.